St. Jude Medical (STJ) Announces FDA Approval, U.S. Launch of Medical Device to Reduce Risk of Recurrent Ischemic Stroke in Patients with PFO
Go back to St. Jude Medical (STJ) Announces FDA Approval, U.S. Launch of Medical Device to Reduce Risk of Recurrent Ischemic Stroke in Patients with PFOSt Jude Medical (NYSE: STJ) | Delayed: 80.82 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $80.82 | 52 Week High | $84.00 | |||
Open | $53.29 | 52 Week Low | $48.83 | |||
Day High | $80.82 | P/E | 32.59 | |||
Day Low | $80.82 | EPS | $2.48 | |||
Volume | 458,525 |